Danofloxacin

Danofloxacin
Clinical data
AHFS/Drugs.comInternational Drug Names
ATCvet code
Identifiers
  • 1-Cyclopropyl-6-fluoro-7-[(1S,4S)-3-methyl-3,6-diazabicyclo[2.2.1]heptan-6-yl]-4-oxoquinoline-3-carboxylic acid
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.166.385
Chemical and physical data
FormulaC19H20FN3O3
Molar mass357.385 g·mol−1
3D model (JSmol)
  • O=C(O)\C4=C\N(c3cc(N1C[C@H]2N(C)C[C@@H]1C2)c(F)cc3C4=O)C5CC5
  • InChI=1S/C19H20FN3O3/c1-21-7-12-4-11(21)8-22(12)17-6-16-13(5-15(17)20)18(24)14(19(25)26)9-23(16)10-2-3-10/h5-6,9-12H,2-4,7-8H2,1H3,(H,25,26)/t11-,12-/m0/s1 X markN
  • Key:QMLVECGLEOSESV-RYUDHWBXSA-N X markN
 X markNcheckY (what is this?)  (verify)

Danofloxacin is a fluoroquinolone antibiotic used in veterinary medicine.[1] It is marketed as A180 by Pfizer,[2] and as Advocin by Zoetis.[3]

References

  1. ↑ Lees P, Shojaee Aliabadi F (April 2002). "Rational dosing of antimicrobial drugs: animals versus humans". International Journal of Antimicrobial Agents. 19 (4): 269–84. doi:10.1016/s0924-8579(02)00025-0. PMID 11978498.
  2. ↑ Center for Veterinary Medicine (September 20, 2002). Freedom of Information Summary: Original New Animal Drug Application (NADA 141-207) – A180 (danofloxacin mesylate) (Report). Food and Drug Administration, Center for Veterinary Medicine. Retrieved August 8, 2026.
  3. ↑ "Animal Drugs @ FDA: NADA 141-207". U.S. Food and Drug Administration. Retrieved August 8, 2026.